Serotonin 5-HT 2A receptor-mediated hypertrophy is negatively regulated by caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 502-510

  Mialet Perez, Jeanne ^a,b   D'Angelo, Romina ^c   Villeneuve, Christelle ^a,b   Ordener, Catherine ^a,b   Nègre Salvayre, Anne ^a,b   Parini, Angelo ^a,b   Vindis, Cécile ^a,b  

^a Université de Toulouse   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Cellular Imaging Facility Plateform IFR150 TRI   (France)

Author keywords

5 HT 2A receptor; Cardiac cell hypertrophy; Caveolae; Caveolin 3; NFAT; Serotonin

Indexed keywords

CAVEOLIN 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN HEAVY CHAIN BETA; SEROTONIN; SEROTONIN 2A RECEPTOR; TRANSCRIPTION FACTOR NFAT;

ANF GENE; ANIMAL CELL; ARTICLE; CARDIOMYOBLAST; CAVEOLA; CELL SIZE; CELL SURFACE; CELL SURFACE AREA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; GENE SILENCING; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; INTRACELLULAR SIGNALING; MALE; MOUSE; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; TRANSCRIPTION INITIATION; ANIMAL; C3H MOUSE; CARDIOMEGALY; CELL LINE; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; CAVEOLAE; CAVEOLIN 3; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE SILENCING; MALE; MICE; MICE, INBRED C3H; MYOBLASTS, CARDIAC; MYOCYTES, CARDIAC; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84855983529     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.07.019     Document Type: Article

References (24)

1. Brattelid T., Qvigstad E., Birkeland J.A., Swift F., Bekkevold S.V., Krobert K.A., et al. Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle. J Mol Cell Cardiol Dec 2007, 43(6):767-779.
2. Levy F.O., Qvigstad E., Krobert K.A., Skomedal T., Osnes J.B. Effects of serotonin in failing cardiac ventricle: signalling mechanisms and potential therapeutic implications. Neuropharmacology Nov 2008, 55(6):1066-1071.
3. Lairez O., Calise D., Bianchi P., Ordener C., Spreux-Varoquaux O., Guilbeau-Frugier C., et al. Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J Mol Cell Cardiol Apr 2009, 46(4):587-595.
4. Villeneuve C., Caudrillier A., Ordener C., Pizzinat N., Parini A., Mialet-Perez J. Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells. Am J Physiol Heart Circ Physiol Aug 2009, 297(2):H821-H828.
5. Vindis C., D'Angelo R., Mucher E., Negre-Salvayre A., Parini A., Mialet-Perez J. Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors. Biochem Biophys Res Commun Jan 1 2010, 391(1):979-983.
6. Ostrom R.S., Insel P.A. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol Sep 2004, 143(2):235-245.
7. Anderson R.G. The caveolae membrane system. Annu Rev Biochem 1998, 67:199-225.
8. Smart E.J., Graf G.A., McNiven M.A., Sessa W.C., Engelman J.A., Scherer P.E., et al. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999, 19(11):7289-7304.
9. Couet J., Sargiacomo M., Lisanti M.P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 1997, 272(48):30429-30438.
10. Watkins S.J., Borthwick G.M., Arthur H.M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim Feb 2011, 47(2):125-131.
11. Foussal C., Lairez O., Calise D., Pathak A., Guilbeau-Frugier C., Valet P., et al. Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett Jun 3 2010, 584(11):2363-2370.
12. Song K.S., Li S., Okamoto T., Quilliam L.A., Sargiacomo M., Lisanti M.P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 1996, 271(16):9690-9697.
13. Vindis C., Cerretti D.P., Daniel T.O., Huynh-Do U. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. J Cell Biol 2003, 162(4):661-671.
14. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem Mar 7 1997, 272(10):6525-6533.
15. Bush E., Fielitz J., Melvin L., Martinez-Arnold M., McKinsey T.A., Plichta R., et al. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci USA Mar 2 2004, 101(9):2870-2875.
16. Koga A., Oka N., Kikuchi T., Miyazaki H., Kato S., Imaizumi T. Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension Aug 2003, 42(2):213-219.
17. Head B.P., Patel H.H., Roth D.M., Lai N.C., Niesman I.R., Farquhar M.G., et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem Sep 2 2005, 280(35):31036-31044.
18. Bhatnagar A., Sheffler D.J., Kroeze W.K., Compton-Toth B., Roth B.L. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem Aug 13 2004, 279(33):34614-34623.
19. Chini B., Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?. J Mol Endocrinol Apr 2004, 32(2):325-338.
20. Ushio-Fukai M., Hilenski L., Santanam N., Becker P.L., Ma Y., Griendling K.K., et al. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem Dec 21 2001, 276(51):48269-48275.
21. Kong M.M., Hasbi A., Mattocks M., Fan T., O'Dowd B.F., George S.R. Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1. Mol Pharmacol Nov 2007, 72(5):1157-1170.
22. Isberg V., Balle T., Sander T., Jorgensen F.S., Gloriam D.E. G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations. J Chem Inf Model Feb 28 2011, 51(2):315-325.
23. Pani B., Singh B.B. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium Jun 2009, 45(6):625-633.
24. Murata T., Lin M.I., Stan R.V., Bauer P.M., Yu J., Sessa W.C. Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. J Biol Chem 2007, 282(22):16631-16643.